The S&P 500 is closing in on its all-time high, and is likely to sail past it, as long as the Fed promises lower interest rates and the trade war calms down.Market Insiderread more
In a tweet, Trump said that he and Xi "had a very good telephone conversation," and that "our respective teams will begin talks prior to our meeting."Politicsread more
A Bloomberg News report Tuesday morning said the White House had looked at such a move in February.Marketsread more
President Donald Trump on Tuesday announced that he will not nominate acting Defense Secretary Patrick Shanahan to hold the position in a permanent capacity. Army Secretary...Politicsread more
Stocks surged after President Donald Trump said he will be meeting with his Chinese counterpart, Xi Jinping, at the upcoming G-20 summit.US Marketsread more
The move is part of a larger trend that saw the survey's 179 participants move away from risk and toward positions that reflect fear of a coming economic slowdown spurred by a...Marketsread more
Democratic frontrunner Joe Biden on Monday appealed to a billionaire Republican donor for fundraising help in his presidential campaign. But the financier, Trump-supporting...Politicsread more
Facebook and other groups are behind a new programming language for working with the Libra blockchain.Technologyread more
Tesla investors are regaining confidence in a quieter Elon Musk — even as they question the company's ability to hit its production goals for the second quarter.Autosread more
Long-time blockchain technologists say Facebook's Libra digital currency will introduce billions to cryptocurrencies, but the company's problems with trust and privacy remain...Technologyread more
Valisure, an online pharmacy company, told the FDA that high levels of dimethylformamide were found in valsartan, a drug produced by Swiss drugmaker Novartis and other...Health and Scienceread more
Citron Research's Andrew Left, who gained attention for successful bets against companies including Valeant Pharmaceuticals, reiterated his negative call and $45 price target on Motorola Solutions.
Left confirmed he is currently short shares of the communications equipment maker in an email to CNBC.
A Motorola Solutions decline to $45 would represent a fall of nearly 50 percent for the shares.
"We continue to believe MSI will play a materially smaller role in the evolving public safety market in the medium-term versus its dominant position today," Left wrote in a new blog post about the company Wednesday. "It is only a matter of time before the market withdraws MSI's high-growth tech stock multiple, and it is repriced for what is left of its business. Losing handset sales will be the initial blow to MSI and service revenue will soon follow."
Motorola Solutions shares were slightly higher in late trading Wednesday. The stock was up 4.3 percent year to date through Tuesday versus S&P 500's 9.5 percent return.
This wasn't the first time Citron expressed a bearish view on Motorola Solutions shares. He predicted the communications equipment maker would face pricing pressure from the government in February.
A Motorola Solutions spokesperson sent the following statement for this story:
"Citron's latest attack is another transparent attempt by a self-interested short-seller to profit, at our shareholders' expense, by manipulating Motorola Solutions' stock price.
Based on numerous reports published by credible third parties, even in the last week, we are encouraged that investors recognize Citron's allegations as false, misleading and demonstrative of a clear misunderstanding of our customers, industry and products.
We are confident that we have the right strategy, products and solutions in place to continue creating shareholder value. We are proud to be a core member of the AT&T team delivering FirstNet with our broadband-enabled devices, mobile applications, software and services. "